fda status bpc-157 tb-500 2026 reviews BPC-157, and other peptides favored by RFK Jr FDA panel votes to place
FDA panel votes to place popular peptide BPC 157 on compounding list KELO AM Peptide Sciences Shuts Down: What Happened (March 2026) WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr. Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

